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Interactions between natural killer 
cells and dendritic cells favour T helper1-type 
responses to BCG in calves
Carly A. Hamilton1* , Suman Mahan3, Gary Entrican1,2 and Jayne C. Hope1
Abstract 
Vaccination of neonatal calves with BCG induces a significant level of protection from infection with Mycobacterium 
bovis, the causative agent of bovine tuberculosis. Since neonatal vaccination of humans with BCG induces activation 
of NK cells, and young calves have high circulating numbers of these cells, we hypothesised that NK cells are impor-
tant in the protective response to BCG. Furthermore, since NK cells play a role in shaping adaptive immune responses 
through interactions with DCs, we investigated the interactions between NK cells and DCs in the context of BCG. DCs 
infected with BCG expressed significantly higher levels of MHC class II and the co-stimulatory molecules CD40 and 
CD80, alongside augmented production of the Th1 polarising cytokine IL-12, when compared with uninfected DCs. 
Following in vitro co-culture with BCG-infected DCs, NK cells increased their expression of the activatory molecule 
CD25, with preferential activation of the CD2− NK cell subset. NK cell effector function, as measured by production of 
IFN-γ, was also significantly enhanced following co-culture with BCG-infected DCs. This study provides novel evidence 
to demonstrate that NK cells phenotypically and functionally mature after interactions with DCs in the context of BCG. 
Furthermore, through the production of IFN-γ and IL-12 by NK cells and DCs respectively, this interaction may drive 
protective Th1-type immune responses to Mycobacteria.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Bovine tuberculosis (bTB), caused by infection of cat-
tle with Mycobacterium bovis (M. bovis), is increasing 
in incidence in the United Kingdom (UK) and currently 
costs the economy up to £100 million per annum to 
control. Vaccination is an aspirational cornerstone for 
future bTB disease control, alongside improved diag-
nostic tests which differentiate infected from vaccinated 
animals (DIVA). However, currently there are no vac-
cines licensed for use in cattle. Despite over a century of 
research, Bacille Calmette Guerin (BCG) which is a live 
attenuated strain of M. bovis, remains the only vaccine 
available for use in humans against TB and is particu-
larly effective when delivered to infants [1, 2]. Similarly, 
a number of studies have demonstrated that experimen-
tal vaccination of neonatal calves with BCG provides 
significant protection against M. bovis infection [3–5]. 
Although the use of BCG in the field is prohibited by EU 
legislation due to non-specific sensitisation to the tuber-
culin skin test, BCG remains the most effective vaccine 
available for use in cattle and the development of new 
DIVA tests may allow it to be deployed in the UK for bTB 
control. Alongside this, understanding the mechanisms 
by which BCG can induce protective immunity in young 
calves could pinpoint targets for improved vaccine design 
or delivery.
BCG vaccination of infant humans induces activation 
of innate effector cells such as natural killer (NK) cells 
and γδ T cells [6]. Since young calves, particularly those 
aged between 8 and 120 days old, have increased circu-
lating numbers of NK cells [7–9], it was hypothesised 
that NK cells may play a role in the enhanced efficacy of 
BCG in neonatal calves. Similar to young calves, human 
infants have elevated levels of NK cells which also decline 
with age [10, 11], therefore research focusing on the role 
of NK cells during mycobacterial infection or vaccination 
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in neonatal calves may also be applicable to studies in 
humans.
NK cells are large granular lymphocytes which were 
identified in the 1970s by their ability to lyse malignant 
or transformed cells without prior sensitisation [12]. This 
heterogeneous cell population has diverse roles in the 
immune system and are the first line of defence in the 
control of viruses, bacteria and parasites [13–16]. NKp46 
is a natural cytotoxicity receptor (NCR) expressed exclu-
sively by NK cells (NCR1; CD335) and commonly used 
as a pan-species marker to identify NK cells [17]. The 
development of a monoclonal antibody (mAb) specific to 
this NCR has facilitated the detailed study of NK cells in 
cattle [18]. Bovine NK cells lack expression of CD3 and 
can be subdivided into NKp46+ CD2+ and NKp46+ 
CD2low or CD2negative (referred to as CD2− herein) 
subsets [18]. These subsets of bovine NK cells differ in 
their localisation, phenotype and function. For exam-
ple, the majority of peripheral blood derived NK cells 
are CD2+ and a small population are CD2−. In con-
trast, CD2− NK cells are the predominant subset found 
within lymph nodes and this subset has also been defined 
as the major NK cell subset present within skin draining 
afferent lymphatic vessels [18, 19]. CD2− NK cells have 
a higher expression of the activation markers CD25 and 
CD44, an increased proliferative capacity and enhanced 
ability to produce IFN-γ in comparison to their CD2+ 
counterparts. However, both subsets have equal cyto-
toxic capacities [20].
NK cells are traditionally regarded as cells of the 
innate immune system but can be viewed as an inter-
face between innate and adaptive immunity due to their 
capacity to drive adaptive immune responses. Early inter-
actions between populations of innate immune cells, par-
ticularly NK cells and dendritic cells (DCs), can influence 
the nature of the adaptive immune response. Protective 
immunity against M. bovis infection in cattle is driven by 
Th1-type immune responses which are characterised by 
IFN-γ production [21]. Initial investigations into bovine 
innate immune cell interactions in the context of myco-
bacteria showed that a population of NK-like cells from 
naïve calves produced IFN-γ after interplay with BCG-
infected DCs [22]. More recently, interactions between 
NKp46+ CD2− NK cells and M. bovis-infected DCs 
were defined and showed that reciprocal interactions 
occur, resulting in activation of both CD2− NK cells and 
DCs [23]. Whether reciprocal interactions between NK 
cells and DCs occur in the context of BCG, and the key 
mechanisms involved, has not been elucidated in cat-
tle. Furthermore, the effect of these interactions on the 
induction of the adaptive immune response is unknown. 
To study the interaction between these two populations 
of innate immune cells, in  vitro co-cultures between 
BCG-infected monocyte-derived DCs and autologous 
NK cells enriched from peripheral blood were estab-
lished. We hypothesised that NK cells required interac-
tions with BCG-infected DCs to become phenotypically 
and functionally mature and the interaction between the 
NK cells and DCs drives Th1-type immune responses. 
To address this hypothesis we developed in  vitro co-
cultures between BCG-infected monocyte-derived DCs 
and autologous NK cells enriched from peripheral blood 
and investigated the phenotypic and functional charac-
teristics of the resulting populations. We demonstrated 
that monocyte-derived DCs increased their expression 
of MHC class II, CD40 and CD80 in response to expo-
sure to BCG in conjunction with enhanced production of 
the Th1 polarising cytokine IL-12. As a result of co-cul-
ture with BCG-infected DCs, NK cells became activated 
and produced increased amounts of IFN-γ, indicating 
that this interaction may drive Th1 immune responses 




Experiments were performed using male British Hol-
stein–Friesian (Bos taurus) calves obtained from the 
Langhill herd, University of Edinburgh which has been 
certified free of bTB for over 10  years. All calves were 
housed at Dryden Farm, University of Edinburgh accord-
ing to Home Office guidelines and with approval from 
The Roslin Institute Local Ethics Committee. Calves were 
under 6 months of age.
Isolation of peripheral blood mononuclear cells (PBMCs)
Blood was collected by jugular venepuncture into sodium 
heparin (Fisher Scientific, UK) and PBMCs were sepa-
rated by density gradient centrifugation using Histo-
paque 1083 (Sigma-Aldrich, UK).
Isolation of CD14+ monocytes and culture 
of monocyte‑derived DCs
CD14+ monocytes were positively selected from PBMCs 
using MACS anti-human CD14 MicroBeads and a Midi-
MACS LS column (Miltenyi Biotec, UK) to purities >98% 
(Additional file  1A). Monocytes were cultured in RPMI 
1640 (Gibco, UK), 10% foetal calf serum (TCS Bio-
sciences Ltd, UK), 5 × 10−5M 2-mercaptoethanol (Sigma 
Aldrich, UK) and 50 µg/mL gentamicin (Sigma-Aldrich, 
UK) supplemented with recombinant bovine GM-CSF 
and IL-4 (generated at Moredun Research Institute, 
UK) for 3  days to obtain immature DCs as previously 
described [24]. DCs were harvested by incubating with 
non-enzymatic cell dissociation fluid (Sigma-Aldrich, 
UK). Floating and adherent cells were pooled together 
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and live DCs were identified by gating as FSChigh SSChigh 
cells (Additional file 1B) which were negative for the dead 
cell discriminator Sytox Blue (Life Technologies, UK) 
(Additional file 1C).
Infection of monocyte‑derived DCs with BCG or 
BCG‑fluorescein isothiocyanate (FITC)
BCG Vaccine Danish strain 1331 (Statens Serum Insti-
tut, Denmark) was prepared by reconstituting lyoph-
ilised BCG with 1 mL of diluted Sauton medium (Statens 
Serum Institut, Denmark). For fluorescent labelling of 
BCG, BCG was mixed with an equal volume of 0.2 mg/
mL FITC (Sigma Aldrich, UK) for 3  h and washed 3 
times prior to infection of monocyte-derived DCs. DCs 
were infected with BCG or BCG-FITC at a multiplicity of 
infection (MOI) of 5 for 42 h.
Isolation of NK cells
NKp46+ NK cells were positively selected from periph-
eral blood by labelling PBMCs with mouse anti-ovine 
CD335 (EC1.1, IgG1, kindly provided by Dr Timothy 
Connelley) and immunomagnetic anti-mouse pan IgG 
Dynabeads (Invitrogen, UK) to purities >95% (Additional 
file  2). NK cells were cultured in RPMI 1640 (Gibco, 
UK) supplemented with 10% foetal calf serum (TCS 
Biosciences Ltd, UK), 5  ×  10−5M 2-mercaptoethanol 
(Sigma-Aldrich, UK) and 50  µg/mL gentamicin (Sigma 
Aldrich, UK). Magnetic beads were removed after 24 h of 
culture using a Dyna-Mag 15 magnet (Invitrogen, UK).
Co‑culture of NK cells with BCG‑infected DCs
BCG-infected DCs or uninfected DCs were co-cultured 
for 18 h with autologous NK cells at a previously deter-
mined optimal NK cell: DC ratio of 5:1 [23]. Following 
co-culture, cells were pelleted and supernatants were 
collected and stored at −20 °C. NK cells cultured alone, 
with BCG (MOI of 5) or supplemented with recombinant 
bovine IL-12 (20 BU/mL) and recombinant human IL-18 
(20 ng/mL) served as control conditions.
Multi‑colour immunofluorescent staining
NK cells were identified by labelling cells with mouse 
anti-bovine CD335-PE (AKS1, IgG1, Bio-Rad AbD Sero-
tec, UK) and mouse anti-bovine CD3 (MM1A, IgG1, 
VMRD, Washington) indirectly conjugated to goat anti-
mouse IgG1-AF647 (Life Technologies, UK). Subsets 
of NK cells were differentiated by labelling with mouse 
anti-bovine CD2-FITC (CC42, IgG1, Bio-Rad AbD 
Serotec). Expression of CD25 was assessed by labelling 
NK cells with mouse anti-bovine CD25 (CACT108A, 
IgG2a, VMRD, Washington) and goat anti-mouse IgG2a-
AF647 (Life Technologies, UK). DCs were identified as 
described in Additional file  1. Mouse anti-bovine MHC 
class II-PE (CC158, IgG2a, Bio-Rad AbD Serotec), mouse 
anti-bovine CD40-FITC (IL-A156, IgG1, Bio-Rad AbD 
Serotec) and mouse anti-bovine CD80 (IL-A159, Bio-Rad 
AbD Serotec) indirectly conjugated to goat anti-mouse 
IgG1-AF647 (Life Technologies, UK) were used to deter-
mine DC expression of MHC class II, CD40 and CD80 
respectively. Live cells were identified using Sytox Blue 
(Life Technologies, UK) and 50 000 events were collected 
using the BD LSRFortessa and FACSDiva Software. 
Gates were established by using Fluorescence Minus 
One (FMO) controls. Data analysis was performed using 
FlowJo v10 software (Treestar Inc, USA).
Enzyme linked immunosorbent assay (ELISA)
ELISAs were performed to detect the presence of bovine 
IL-12 [25] and IFN-γ [26] as previously described. 
Absorbance was measured at 450  nm subtracted from 
690  nm using the Synergy HT Multi-Mode Microplate 
Reader and Gen 5 software.
Data analysis
Data analysis was performed using Microsoft Excel 2010 
and GraphPad Prism 6. Statistical analysis was completed 
using Minitab v16. Distribution of data was assessed 
using a normality test with p  >  0.05 deemed to be nor-
mally distributed data. Statistical methods used are 
detailed in individual figure legends. p < 0.05*, p < 0.01** 
and p < 0.001***.
Results
Infection of bovine monocyte‑derived DCs with BCG 
results in increased expression of MHC class II, CD40, CD80 
and production of the Th1 polarising cytokine IL‑12
To assess the percentage of monocyte-derived DCs 
infected by BCG, DCs were exposed to fluorescently 
labelled BCG at an MOI of 5. BCG infected a significant 
proportion of immature DCs with 64.5% (48.2–75.8%; 
SD = 14.1) shown to contain BCG-FITC (Figure 1A). The 
effect of BCG on the phenotype of DCs was investigated 
by comparing the expression of MHC class II (Figure 1B) 
and the co-stimulatory molecules CD40 (Figure 1C) and 
CD80 (Figure 1D) by uninfected and BCG-infected DCs. 
Expression of MHC class II (p < 0.001), CD40 (p = 0.032) 
and CD80 (p  =  0.044) were significantly enhanced fol-
lowing infection of DCs with BCG compared with unin-
fected DCs. Uninfected DCs expressed MHC class I and 
CD86, however no significant increases were observed 
in the expression of these molecules by BCG-infected 
DCs (data not shown). Since protective immunity against 
M. bovis infection in cattle is driven by Th1 polarised 
immune responses [21], production of the Th1 polarising 
cytokine IL-12 by uninfected and BCG-infected DCs was 
measured. DCs infected with BCG secreted significantly 
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Figure 1 BCG is taken up by bovine monocyte-derived DCs resulting in increased the expression of MHC class II, CD40 and CD80 and 
production of the Th1 polarising cytokine IL-12. Monocyte-derived DCs were cultured for 3 days and infected with FITC-labelled BCG (MOI 
5) for 42 h. FACS plots from one representative animal (A) illustrate the percentage uptake of BCG-FITC by uninfected DCs (blue histogram) and 
BCG-infected DCs (pink histogram). Gates were set using uninfected DCs. Pooled data from four calves (A) illustrate the average percentage uptake 
of BCG-FITC ± SD by uninfected DCs (lighter bar) and BCG-infected DCs (darker bar). Uninfected and BCG-infected DCs were labelled with mAbs 
for MHC class II, CD40 and CD80 and analysed by flow cytometry. FACS plots from one representative animal show the expression of MHC class II 
(B), CD40 (C) and CD80 (D) by uninfected (blue histograms) and BCG-infected DCs (pink histograms). Positive cells were identified based on FMO 
controls (green histograms). Pooled data from four calves indicates the average MFI ± SD of MHC class II (B), CD40 (C) and CD80 (D) expression 
by uninfected (lighter bars) and BCG-infected DCs (darker bars). Supernatants were retrieved from uninfected and BCG-infected DCs and assayed 
for IL-12 production by ELISA. Pooled data from five calves represent the average levels ± SD of IL-12 BU/mL produced by uninfected (lighter bars) 
and BCG-infected DCs (darker bars) (E). Data were normally distributed (p > 0.05) and significance between uninfected and BCG-infected DCs was 
assessed using a 2-sample t test. p < 0.05*, p < 0.001***.
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higher levels of IL-12 (p =  0.023) compared with unin-
fected DCs (Figure 1E).
CD25 expression by bovine CD2− NK cells was significantly 
increased following co‑culture with autologous 
BCG‑infected DCs
In vitro co-cultures between BCG-infected DCs and 
autologous NK cells were established to assess the inter-
action between NK cells and DCs in the context of BCG. 
CD25 was used to assess the activation status of NK 
cells after in  vitro co-culture with BCG-infected DCs. 
CD25 expression, as represented by the mean fluo-
rescence intensity (MFI), was low when NK cells were 
cultured with media, with BCG and with uninfected 
DCs (Figure  2B). During co-culture with BCG-infected 
DCs, NK cell expression of CD25 was significantly 
increased compared with NK cells cultured with media 
(p  =  0.009), with BCG (p  =  0.009) or with uninfected 
DCs (p = 0.012). NK cells supplemented with IL-12 and 
IL-18 (positive control), had a high expression of CD25 
(Figure  2B). In addition to enhanced CD25 expression 
(as assessed by MFI) a similar significant increase in the 
percentage of CD25+ NK cells present after culture with 
BCG-infected DCs was evident compared with the per-
centage of CD25+ NK cells present after culture of NK 
cells with media (p = 0.005), with BCG (p = 0.004) and 
with uninfected DCs (p =  0.034) (Figure 2C). To deter-
mine if the observed activation of NK cells in response 
to co-culture with BCG-infected DCs (Figures  2A–C) 
was attributed to a particular subset of bovine NK cells, 
the expression of CD25 by CD2+ and CD2− subsets of 
NK cells was assessed. Expression was compared fol-
lowing culture of NK cells with media, BCG, uninfected 
DCs, BCG-infected DCs or when stimulated with IL-12 
and IL-18. CD25 expression did not significantly differ 
between CD2+ and CD2− subsets when NK cells were 
cultured with media, BCG, uninfected DCs or with IL-12 
and IL-18. However, after culture with BCG-infected 
DCs, CD2− NK cells had a significantly higher expres-
sion of CD25 than CD2+ NK cells (p = 0.017) reflecting 
preferential activation of CD2− NK cells (Figure 2D).
A population of NKp46+ CD3+ lymphocytes which 
have shared attributes of both bovine NK cells and T 
cells has recently been described [27]. As the enrichment 
technique used herein to isolate bovine NK cells from 
peripheral blood involves positively selecting the total 
NKp46+ population, the observed activation of NK cells 
as a result of in vitro co-culture with BCG-infected DCs 
(Figures 2A–C) could be due (at least in part) to activation 
of these double positive cells and not solely to NKp46+ 
CD3- NK cells. To address whether NKp46+ CD3+ cells 
were activated after co-culture with BCG-infected DCs, 
the expression of CD25 was analysed on NKp46+ CD3+ 
and NKp46+ CD3− cells. CD3− cells accounted for a sig-
nificantly higher (p  <  0.001) percentage of the NKp46+ 
CD25+ population in comparison to CD3+ cells, with 
98.4% (97.7–98.9%; SD  =  0.51) of the NKp46+ CD25+ 
population being CD3− (Additional file 3).
Production of IFN‑γ by bovine NK cells was significantly 
increased following co‑culture with autologous 
BCG‑infected DCs
In addition to the activation status of NK cells, the 
effector function of NK cells following co-culture with 
BCG-infected DCs was investigated by determining pro-
duction of IFN-γ. Supernatants were retrieved from co-
culture experiments and assayed for IFN-γ by ELISA. 
IFN-γ production was low when NK cells were cultured 
with media, with BCG or with uninfected DCs. Following 
co-culture with BCG-infected DCs, NK cell production 
of IFN-γ was significantly augmented compared with 
NK cells cultured with media (p = 0.020), NK cells cul-
tured with BCG (p = 0.021) and NK cells cultured with 
uninfected DCs (p = 0.021). NK cells supplemented with 
IL-12 and IL-18 (positive control) produced high levels 
of IFN-γ (Figure  3A). Supernatants were retrieved from 
co-culture experiments and assayed for the presence of 
IL-12 by ELISA. As illustrated previously (Figure  1E), 
DCs secreted elevated levels of IL-12 upon infection 
with BCG compared with the very low levels produced 
by uninfected DCs. Similar to DCs cultured with media 
alone, uninfected DCs cultured with NK cells produced 
low levels of IL-12. Addition of NK cells to BCG-infected 
DCs did not significantly increase the level of IL-12 pro-
duced by BCG-infected DCs alone (Figure 3B).
Discussion
To determine the effect of BCG on interactions between 
NK cells and monocyte-derived DCs, in vitro co-cultures 
between these two populations of innate immune cell 
populations were established. Prior to assessment of the 
effect of co-culture with BCG-infected DCs on the acti-
vation and effector function of NK cells, the influence 
of the vaccine strain BCG Danish on DC phenotype and 
cytokine production was determined. CD14+ monocytes 
cultured with recombinant bovine GM-CSF and IL-4 for 
3  days represent a population of immature monocyte-
derived DCs [24]. Immature monocyte-derived DCs 
ingested BCG as illustrated by the uptake of fluores-
cently labelled bacteria (Figure  1A). Receptors involved 
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in the uptake of mycobacteria by human and murine DCs 
include dendritic cell-specific ICAM-3-grabbing nonin-
tegrin (DC-SIGN) [28], Toll-like receptor (TLR) 2 [29], 
TLR4 [30] and TLR9 [31]. Similarly, a role for DC-SIGN 
in the uptake of BCG by bovine monocyte-derived DCs 
was confirmed when it was demonstrated that blocking 
DC-SIGN with a polyclonal antibody reduced binding of 
green fluorescent protein (GFP)-labelled BCG [32]. Upon 
antigen uptake, immature DCs undergo maturation 
characterised by the upregulation of MHC class I, MHC 
class II and costimulatory molecules, including CD40, 
CD80 and CD86 [33]. Following uptake of BCG by bovine 
monocyte-derived DCs, DCs significantly increased 
their expression of MHC class II (Figure 1B), CD40 (Fig-
ure  1C) and CD80 (Figure  1D) reflecting maturation of 
DCs in response to BCG. This is in line with published 
data whereby DCs infected with BCG Pasteur showed an 
increased expression of MHC class II, CD40 and CD80 
Figure 2 CD25 expression by bovine CD2− NK cells was significantly increased following co-culture with autologous BCG-infected 
DCs. Monocyte-derived DCs were cultured for 3 days and infected with BCG (MOI 5) for 24 h. Autologous NKp46+ cells were enriched from periph-
eral blood and cultured with BCG-infected DCs at a ratio of 5 NK cells per DC. NK cells cultured with media, BCG, uninfected DCs or with recom-
binant bovine IL-12 and recombinant human IL-18 served as controls. After 18 h of co-culture, cells were labelled with mAbs for NKp46, CD2 and 
CD25 and analysed by flow cytometry. FACS plots from one representative animal illustrate the expression of CD25 by NKp46+ NK cells after culture 
with media, BCG, uninfected DCs, BCG-infected DCs or with IL-12 and IL-18 (A). Positive cells were identified based on FMO controls. Pooled data 
from five calves illustrate the average MFI ± SD of CD25 expression by NK cells (B). Pooled data from five calves displays the average percentage of 
CD25+ NK cells ± SD (C). Pooled data from five calves indicate the average MFI ± SD of CD25 expression by CD2+ (lighter bars) and CD2− (darker 
bars) NK cells (D). Data were normally distributed (p > 0.05) and significance between co-culture conditions was assessed using 2-sample t tests. 
p < 0.05*, p < 0.01**.
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[34]. Taken together, this provides evidence that bovine 
monocyte-derived DCs undergo maturation in response 
to BCG Pasteur and to the human vaccine strain BCG 
Danish. In parallel with phenotypic maturation in 
response to antigen uptake, DCs also secrete cytokines 
which direct adaptive immune responses, and there-
fore link the innate and the adaptive immune response. 
Naïve CD4+ T cells can differentiate into various sub-
sets of CD4+ T helper cells which is dictated in part by 
the cytokine milieu present at the time of differentia-
tion. For example, the presence of IL-12 and IFN-γ in the 
local environment results in the development of a Th1 
immune response whereas the presence of IL-4 directs 
a Th2 immune response [35]. Given that a Th1 domi-
nant response is likely to be most effective against M. 
bovis infection, the production of IL-12 by uninfected 
and BCG-infected DCs was quantified. BCG-infected 
DCs produced significant levels of IL-12 after infec-
tion with BCG indicating that BCG-infected DCs could 
contribute significantly to the induction of a CD4+ Th1 
immune response. Bovine DCs have been shown previ-
ously to secrete IL-12 after infection with M. bovis and 
the Pasteur strain of BCG [34]. The results presented in 
Figure 1E demonstrate that DCs can also produce IL-12 
when stimulated with the vaccine strain of BCG.
After establishing that DCs undergo maturation in 
response to infection with BCG (Figures 1B–D) and pro-
duced elevated levels of the Th1 polarising cytokine IL-12 
(Figure  1E), the effect of BCG-infected DCs on NK cell 
activation was investigated by assessing NK cell expres-
sion of CD25. CD25 expression was significantly aug-
mented when NK cells were cultured with BCG-infected 
DCs, reflecting activation of NK cells in response to co-
culture with DCs in the context of BCG (Figures 2A–C). 
CD25 is the α chain of the IL-2R and together with the 
IL-2Rβ and γ chains allows IL-2 signalling through the 
IL-2R, therefore data presented in Figures  2A–C sug-
gests NK cells are more responsive to IL-2 following co-
culture with BCG-infected DCs. The observed activation 
of NK cells after in  vitro co-culture with BCG-infected 
DCs was due to preferential activation of the CD2− sub-
set of NK cells illustrated by a significantly higher CD25 
expression by CD2− NK cells compared with CD2+ NK 
cells (Figure  2D). Interestingly, in the positive control 
whereby NK cells were stimulated with IL-12 and IL-18, 
there was not a significant difference between the expres-
sion of CD25 by the two subsets, indicating that the 
increased activation of CD2− NK cells after co-culture 
with BCG-infected DCs was unique to these conditions. 
This preferential activation of bovine CD2− NK cells 
was also apparent when NK cells were cultured with M. 
bovis-infected DCs [23] showing that CD2− NK cells 
are favourably activated when NK cells are cultured with 
DCs in vitro in the context of both BCG and M. bovis. In 
line with this finding, CD2− NK cells are the main sub-
set of NK cells migrating in bovine afferent lymph [19], 
they preferentially migrate towards M. bovis-infected 
Figure 3 IFN-γ production by NK cells was significantly 
increased following co-culture with autologous BCG-infected 
DCs. Monocyte-derived DCs were cultured for three days and 
infected with BCG (MOI 5) for 24 h. Autologous NKp46+ cells were 
enriched from peripheral blood and cultured with BCG-infected DCs 
at a ratio of 5 NK cells per DC. NK cells cultured with media, BCG, 
uninfected DCs or with recombinant bovine IL-12 and recombinant 
human IL-18 served as controls. After 18 h of co-culture, supernatants 
were assayed for IFN-γ and IL-12 production by ELISA. Pooled data 
from five calves represents the average levels ± SD of IFN-γ (pg/
mL) produced (A). Pooled data from five calves represents the aver-
age levels ± SD of IL-12 (BU/mL) produced (B). Data were normally 
distributed (p > 0.05) and significance between co-culture conditions 
was assessed using 2-sample t tests; p < 0.05*.
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DCs during in  vitro chemotaxis assays [23] and are key 
producers of IFN-γ [20]. Therefore, we hypothesise that 
CD2− NK cells migrate to lymph nodes in  vivo where 
they interact with DCs, resulting in NK cell activation. 
It was also demonstrated in Additional file 3 that activa-
tion of NKp46+ cells after co-culture with BCG-infected 
DCs was specific to NKp46+ CD3− NK cells and that 
a recently characterised subset of lymphocytes that co 
express NKp46 and CD3 were not activated by co-culture 
with BCG-infected DCs [27].
Production of immunoregulatory cytokines, primar-
ily IFN-γ, is a key functional property of NK cells and 
in parallel with IL-12, early production of IFN-γ drives 
Th1 polarised immune responses. NK cell production of 
IFN-γ was significantly augmented when NK cells were 
co-cultured with BCG-infected DCs (Figure  3A), dem-
onstrating that production of IFN-γ by NK cells after 
co-culture with BCG-infected DCs has the potential 
to prime Th1-type immunity. Murine NK cells polar-
ise Th1 immune responses through interactions with 
DCs [36] and enhanced secretion of IFN-γ by NK cells 
was also noted after reciprocal interactions with M. tb-
infected DCs [37]. Within the present study, the subset 
of NK cells responsible for the increased IFN-γ produc-
tion following co-culture with BCG-infected DCs was 
not defined. However, bovine CD2− NK cells have an 
increased capacity to produce IFN-γ compared with 
CD2+ NK cells [20]. Furthermore, CD2− NK cells are 
the subset responsible for production of IFN-γ after cul-
ture with M. bovis-infected DCs [23]. Therefore, we pro-
pose that CD2− NK cells are the major IFN-γ producers 
following co-culture with BCG-infected DCs. Studies in 
humans have shown that BCG can bind directly to NK 
cells through NK cell expression of TLR2 and NKp44 
and induce NK cell production of IFN-γ [38–40]. Nev-
ertheless, BCG alone had no effect on the production of 
IFN-γ by NK cells (Figure 3A), or on the activation of NK 
cells (Figures 2A–C). Despite TLR2 being transcribed by 
bovine NK cells (Nazneen Siddiqui, PhD thesis, Imperial 
College, 2011), expression of TLR2 was not detected on 
the surface of NK cells (data not shown). Furthermore, 
NKp44 is a pseudogene in cattle [41] therefore combined 
with the lack of surface TLR2, may explain why there was 
no direct recognition of BCG by bovine NK cells in this 
study.
Data presented herein demonstrates that BCG-
infected DCs provide signals to NK cells which induce 
phenotypical and functional changes, however NK 
cells are also thought to modulate the response of 
DCs in a reciprocal interaction. Thus, the effect of NK 
cells on the production of IL-12 by BCG-infected DCs 
was assessed. The addition of NK cells increased the 
amount of IL-12 produced by BCG-infected DCs alone; 
although this was not significant (Figure  3B). NK cells 
express receptors for IL-12 [42] and as the superna-
tants were retrieved 18  h after co-culture with BCG-
infected DCs, it is possible that the presence of NK cells 
enhanced the production of IL-12 by BCG-infected 
DCs through the release of IFN-γ, and this IL-12 was 
subsequently utilised by NK cells expressing IL-12R. In 
mice, DCs that have been in contact with NK cells were 
shown to increase secretion of IL-12 [43] and in cattle, 
M. bovis-infected DCs showed enhanced expression of 
MHC class II after interactions with autologous periph-
eral blood NK cells [23]. Hence, NK cells may influence 
the adaptive immune response by inducing effective 
antigen presenting cells (APC). The production of Th1 
polarising cytokines IFN-γ and IL-12 during the co-cul-
ture between NK cells and BCG-infected DCs suggests 
that this interaction may contribute to the induction of 
Th1 immune responses.
The mechanisms underlying the interactions between 
bovine NK cells and DCs in the context of BCG have not 
yet been elucidated. Both soluble factors and contact-
dependent receptor ligand interactions are thought to 
be important. Since uninfected DCs (which have a low 
expression of MHC class II, CD40 and CD80, and very 
low levels of IL-12) did not stimulate NK cell activation 
(Figures 2A–C) or production of NK cell derived IFN-γ 
(Figure 3A), we hypothesise that IL-12, CD40 and CD80 
are likely to be key molecules involved in the cross-talk 
between NK cells and DCs.
To conclude, in this study bovine NK cells required 
interactions with BCG-infected DCs for optimal acti-
vation and production of IFN-γ in  vitro. Furthermore, 
CD2− NK cells preferentially interacted with DCs in 
the context of BCG highlighted by their increased acti-
vation compared with their CD2+ counterparts. CD2− 
NK cells are abundant within bovine afferent lymph 
[19] and lymph nodes [44] and therefore may traffic to 
lymph nodes and interact with DCs in  vivo. Through 
the secretion of IFN-γ and IL-12 by NK cells and BCG-
infected DCs respectively, this interaction generated 
a cytokine milieu favourable to polarisation of Th1 
immune responses which are thought to be important in 
the protective immune response against M. bovis infec-
tion of cattle. The interaction between bovine CD2− NK 
cells and DCs may represent a target for future novel 
vaccination strategies to initiate Th1 polarised immune 
responses during BCG vaccination of neonatal calves.
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